| Commercial BPA Manager |
Montreal |
Canada |
International |
Innovative Medicines |
Audit & Finance |
Окт. 08, 2024 |
| Site Finance Head |
Morris Plains |
USA |
Finance |
Innovative Medicines |
Audit & Finance |
Окт. 04, 2024 |
| Digital Finance, Data & Tools Analyst |
Barcelona Gran Vía |
Spain |
Finance |
CTS |
Audit & Finance |
Окт. 11, 2024 |
| Financial Reporting & Accounting Specialist |
Baarle Nassau |
Netherlands |
Finance |
Sandoz |
Audit & Finance |
Окт. 11, 2024 |
| Senior Finance Specialist – Digital Analytics and Operations |
Barcelona Gran Vía |
Spain |
Finance |
Innovative Medicines |
Audit & Finance |
Окт. 11, 2024 |
| Tax Specialist |
Mumbai (Head Office) |
India |
Finance |
Corporate |
Audit & Finance |
Окт. 14, 2024 |
| Manager, Digital Finance |
Hyderabad (Office) |
India |
Finance |
Innovative Medicines |
Audit & Finance |
Окт. 09, 2024 |
| Revenue Deduction & Accounting Statutory Lead |
Warsaw |
Poland |
Finance |
CTS |
Audit & Finance |
Окт. 10, 2024 |
| R2R Team Lead - GL & Reporting |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Окт. 10, 2024 |
| Senior Manager - Direct tax |
Mumbai (Head Office) |
India |
Finance |
Corporate |
Audit & Finance |
Окт. 10, 2024 |
| BPA (Budget & Planning Analyst) |
İstanbul Kurtköy |
Turkey |
Finance |
Innovative Medicines |
Audit & Finance |
Окт. 10, 2024 |
| LDC Core Enablement Business and IT Controls |
Hyderabad (Office) |
India |
Operations |
CTS |
Audit & Finance |
Окт. 09, 2024 |
| Investor Relations Executive Director |
East Hanover |
USA |
Finance |
Corporate |
Audit & Finance |
Авг. 28, 2024 |
| Senior Accountant, Tax |
Shanghai (Shanghai) |
China |
Finance |
Corporate |
Audit & Finance |
Авг. 29, 2024 |
| R2R Senior Specialist - Inventory |
Selangor |
Malaysia |
Finance |
CTS |
Audit & Finance |
Окт. 02, 2024 |
| Associate, Record-to-Report |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
Юни 26, 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit & Finance |
Юли 17, 2024 |
| TA Strategy Lead - GenMed |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 02, 2024 |
| CX strategy |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 04, 2024 |
| TA Strategy Lead, RLT (Prostate Cancer) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 07, 2024 |
| Lead, Integrated Insights & Planning_市場調査 |
Head Office (Japan) (Pharmaceuticals) |
Japan |
International |
Innovative Medicines |
Marketing |
Окт. 07, 2024 |
| Business Excellence & Execution IM Head, Mexico |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Окт. 17, 2024 |
| Business Excellence & Execution IM Head, Mexico |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Окт. 17, 2024 |
| Innovation & Business Excellence Project Manager |
Milano |
Italy |
International |
Innovative Medicines |
Marketing |
Окт. 08, 2024 |
| Integrated Business Insight Manager |
Milano |
Italy |
International |
Innovative Medicines |
Marketing |
Окт. 11, 2024 |
| Business Excellence & Execution IM Head, Mexico |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Окт. 17, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Business Excellence & Execution IM Head, Mexico |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Окт. 17, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Business Excellence & Execution IM Head, Mexico |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Окт. 17, 2024 |
| Business Excellence & Execution IM Head, Mexico |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Marketing |
Окт. 17, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Manager, AI Operations |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Окт. 16, 2024 |
| HealthTech Solutions Manager |
Metamorfosis |
Greece |
International |
Innovative Medicines |
Marketing |
Окт. 16, 2024 |
| Strategy Manager |
Taipei |
Taiwan |
International |
Innovative Medicines |
Marketing |
Юли 24, 2024 |
| Team Leader |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Септ. 03, 2024 |
| Customer Experience Manager ST |
Bucuresti |
Romania |
International |
Innovative Medicines |
Marketing |
Юли 31, 2024 |
| Strategic Design Commercial Contracts Manager |
Barcelona Gran Vía |
Spain |
Operations |
CTS |
Marketing |
Септ. 24, 2024 |
| Content Healthcare Manager (m/w/d) in Voll- und Teilzeit |
Munich (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Marketing |
Окт. 14, 2024 |
| Senior Marketing Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Май 15, 2024 |
| Head of Customer Strategy & Operations |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Септ. 03, 2024 |
| Analyst – Patient Oriented Programs |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Analyst - SFE Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 20, 2024 |
| Senior Analyst - Data & Products |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Май 22, 2024 |
| Center Operation Manager |
Chengdu (Sichuan Province) |
China |
International |
Innovative Medicines |
Marketing |
Септ. 03, 2024 |
| Center Operation Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Септ. 03, 2024 |
| Center Operation Manager |
Beijing (Beijing) |
China |
International |
Innovative Medicines |
Marketing |
Септ. 03, 2024 |